Skip to main content
. 2014 Jul 3;8(5):567–573. doi: 10.1111/irv.12264

Table 1.

Factors associated with RV type among patients hospitalized with severe acute respiratory illness, South Africa, 2009–2010

Factor Univariable analysis Multivariable analysis*


RV-A** RV-B RV-C RV-B RV-C


n/N (%) n/N (%) RRR*** (95% CI) n/N (%) RRR*** (95% CI) RRR (95% CI) RRR (95% CI)
Age group, yrs
 <5 78/162 (48) 9/39 (23) 1 90/156 (58) 1 1 1
 5–14 9/162 (6) 1/39 (3) 0·9 (0·1–8·5) 10/156 (6) 0·9 (0·4–2·5) 1·1 (0·1–9·3) 0·9 (0·3–2·2)
 15–24 9/162 (6) 2/39 (5) 1·9 (0·3–10·3) 6/156 (4) 0·6 (0·2–1·7) 1·8 (0·3–9·5) 0·6 (0·2–1·9)
 25–44 42/162 (26) 19/39 (49) 3·9 (1·6–9·4) 38/156 (24) 0·8 (0·5–1·3) 3·5 (1·4–8·5) 0·9 (0·5–1·6)
 45+ 24/162 (15) 8/39 (20) 2·9 (1·1–8·3) 12/156 (8) 0·4 (0·2–0·9) 2·6 (0·9–7·8) 0·4 (0·2–0·9)
Sex (male) 82/162 (51) 13/39 (33) 0·5 (0·2–1·1) 75/156 (48) 0·9 (0·6–1·4)
Year
 2009 52/162 (33) 6/39 (15) 1 85/156 (54) 1 1
 2010 109/162 (66) 33/39 (85) 2·7 (1·1–6·7) 71/156 (46) 0·4 (0·2–0·6) 2·0 (0·7–5·2) 0·4 (0·3–0·7)
Duration of symptoms >2 days 115/162 (71) 33/39 (85) 2·4 (0·9–5·7) 101/156 (65) 0·7 (0·5–1·2)
Length of hospitalization >5 days 68/161 (42) 25/39 (64) 2·4 (1·2–5·0) 58/155 (37) 0·8 (0·5–1·3)
HIV infection 71/153 (46) 26/37 (70) 2·7 (1·2–5·9) 60/135 (44) 0·8 (0·5–1·3)
Asthma†† 5/162 (3) 1/39 (2) 0·8 (0·1–7·2) 10/156 (6) 2·1 (0·7–6·4) 0·6 (0·1–5·5) 3·4 (1·1–11·1)
Underlying illness††† 15/162 (9) 2/39 (5) 0·5 (0·1–2·4) 16/156 (10) 1·1 (0·5–2·3)
Oxygen therapy 56/161 (35) 20/39 (51) 2·0 (0·9–4·0) 63/156 (40) 1·3 (0·8–2·0)
Patient died 8/162 (5) 1/39 (3) 0·5 (0·1–4·2) 8/156 (5) 1·0 (0·4–2·8
*

Reference group for the multinomial regression model.

**

Unadjusted relative risk ratio (RRR) at univariable analysis.

***

Adjusted relative risk ratio (aRRR) at multivariable analysis.

Only covariates significant at the multivariable analysis are reported.

††

Asthma was defined in our database as a history of asthma no distinction was made if they were undergoing an exacerbation of their asthma.

†††

Underlying illness includes: chronic lung diseases, cirrhosis/liver failure, chronic renal failure, heart failure, valvular hearth disease, coronary heart disease, immunosuppressive therapy, splenectomy, diabetes, burns, kwashiorkor/marasmus, nephritic syndrome, spinal cord injury, seizure disorder or emphysema. RRR highlighted in bold indicates factors significant at P < 0·05.